<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03979898</url>
  </required_header>
  <id_info>
    <org_study_id>biostar-CP</org_study_id>
    <nct_id>NCT03979898</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP</brief_title>
  <acronym>CP</acronym>
  <official_title>Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Cerebral Palsy (CP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>R-Bio</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kyung Hee University Hospital at Gangdong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>R-Bio</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety and Effectiveness of Autologous Adipose Tissue Derived mesenchymal Stem Cell
      Implantation in Patients with CP
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to investigate the efficacy and safety of autologous
      transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with
      Cerebral Palsy(CP)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2017</start_date>
  <completion_date type="Actual">May 13, 2019</completion_date>
  <primary_completion_date type="Actual">April 23, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Kaufman Assessment Battery for Children (K-ABC)</measure>
    <time_frame>Baseline and 12 month</time_frame>
    <description>Change from Baseline K-ABC at 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood concentration test</measure>
    <time_frame>Baseline, 1, 3, 6 and 12 month</time_frame>
    <description>Change from baseline concentration of dopamine, acetylcholine, serotonin at 1, 3, 6 and 12 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gross Motor Function Measurement (GMFM)</measure>
    <time_frame>Baseline, 3, 6 and 12 month</time_frame>
    <description>Change from Baseline GMFM at 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Box and Block Test</measure>
    <time_frame>Baseline, 3, 6 and 12 month</time_frame>
    <description>Change from Baseline Box and block test at 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Ashworth Scale (MAS)</measure>
    <time_frame>Baseline, 3, 6 and 12 month</time_frame>
    <description>Measurement of resistance during soft-tissue stretching
Scale range is 0(no increase in muscle ton) to 4(affected part rigid in flexion or extension)
Change from Baseline MAS at 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>Baseline, 3, 6 and 12 month</time_frame>
    <description>SF-36 is a survey to measure Mental &amp; Physical Health
Score range is 0 to 100(the lower the score, the more disability)
Change from Baseline SF-36 at 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verification of ASTROSTEM's effect on the brain through fMRI &amp; MRS (Magnetic Resonance Spectroscopy) scan</measure>
    <time_frame>Baseline, 6 and 12 month</time_frame>
    <description>Changes in fMRI &amp; MRS scan from baseline to 6, 12 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kaufman Assessment Battery for Children (K-ABC)</measure>
    <time_frame>Baseline and 6 month</time_frame>
    <description>Change from Baseline K-ABC at 6 months</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Astrostem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Autologous Adipose Tissue Derived Mesenchymal Stem Cells</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ASTROSTEM</intervention_name>
    <description>Intravenous injection of Autologous Adipose derived mesenchymal stem cells. Dose : 15kg below : 0.5x10^7cells/5mL 15kg ~ 25kg : 1x10^8cells/10mL 25kg over : 1.5x10^8cells/15mL</description>
    <arm_group_label>Astrostem</arm_group_label>
    <other_name>Autologous Adipose Tissue Derived Mesenchymal Stem Cells</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with spastic cerebral palsy of spastic paraplegia or quadriplegia involving
             the two side occurred at birth or before birth

          -  Age : 36 months - 12 year, males and females

          -  Subjects who understand and sign the consent form for this study

          -  Kaufman Assessment Battery for Children 50&lt;K-ABC&lt;100

        Exclusion Criteria:

          -  The last three months had seizures or epilepsy patients taking the durg

          -  Genetic Diseases

          -  Recent cancer patients within 1 year

          -  patients witn a psychiatric disorder that may interfere in the clinical trial

          -  participating another clinical trials within 3 months

          -  Recently there is a change of the abrupt symptoms within three months of the patient

          -  Subjects with a infectious disease include HIV and VDRL

          -  Patients who penicillin hypersensitivity reactions

          -  Other pathologic conditions or circumstances that difficult participation in the study
             according to medical criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>36 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>KyungHee University Gandong Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>June 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>June 6, 2019</last_update_submitted>
  <last_update_submitted_qc>June 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

